4
Changes in Ownership
Processa Pharmaceuticals, Inc. Filed Acc 0000897069-25-001545
Options or other derivatives
- Pres. Research & Development acquired 444,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Young David Pres. Research & Development | 2025-10-01 | Grant or award · Restricted Stock Units | +111,000 | 111,000 | D | ||
| Young David Pres. Research & Development | 2025-10-01 | Grant or award · Stock Options (Right to Buy) | +333,000 | 333,000 | D | ||
Loading xslF345X05/form4.xml…